ATACAND HCT

Product NDC: 0186-0162
11-digit product format: 001860162
Labeler code: 0186
Product ID: 0186-0162_9e314974-b835-461b-b4f4-9f3660ea83ae
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Candesartan cilexetil and Hydrochlorothiazide
Dosage form: TABLET
Route: ORAL
Labeler: AstraZeneca Pharmaceuticals LP
Application: NDA021093
Marketing category: NDA
Marketing start: 2000-09-28
Marketing end: 2019-07-31
Substance: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Active strength: 16 mg/1; mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0186-0162		D	Discontinued by firm	2026-08-03
excluded package	package	0186-0162	0186-0162-28	D	Discontinued by firm	2026-08-03
excluded package	package	0186-0162	0186-0162-54	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0186-0162-54	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0186-0162-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0186-0162-54	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0186-0162-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0186-0162-54	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0186-0162-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0186-0162-54	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0186-0162-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0186-0162-54	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0186-0162-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0186-0162-54	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0186-0162-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0186-0162-54	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0186-0162-28	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0186-0162-54	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0186-0162-28	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0186-0162-54	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0186-0162-28	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0186-0162-54	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0186-0162-28	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0186-0162-54	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0186-0162-28	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0186-0162-54	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0186-0162-28	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021093-001	ATACAND HCT	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05
N021093-002	ATACAND HCT	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05
N021093-003	ATACAND HCT	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N021093-001	AB
N021093-002	AB
N021093-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021093-002	ATACAND HCT	32MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021093-003	ATACAND HCT	32MG;25MG	TABLET / ORAL	AB	RLD, RS	2008-05-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021093-001	ATACAND HCT	16MG;12.5MG	TABLET / ORAL	AB	RLD	2000-09-05	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021093-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021093-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021093-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021093-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021093-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021093-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021093-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021093-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021093-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021093-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021093-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021093-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021093-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021093-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021093-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021093-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021093-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021093-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021093-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021093-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021093-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021093-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021093-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021093-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021093-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021093-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021093-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021093-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021093-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021093-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021093-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021093-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021093-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021093-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021093-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021093-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021093-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021093-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021093-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021093-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
03f056e9-4354-02cc-6010-79c6c9eaac0a	Product name	6	20250521
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0186-0162-28	EA - Each	0186-0162	e6574eed-1ff8-41a0-8a9c-a970d09a1cc4	1	2012-07-24
0186-0162-54	EA - Each	0186-0162	b6a5da02-9fd2-4eef-ab24-a9935b571b13	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CANDESARTAN CILEXETIL	ACTIVE INGREDIENT	R85M2X0D68	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
CANDESARTAN	ACTIVE MOIETY	S8Q36MD2XX	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
CARBOXYMETHYLCELLULOSE CALCIUM	INACTIVE INGREDIENT	UTY7PDF93L	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]	18
CANDESARTAN CILEXETIL	ACTIVE INGREDIENT	R85M2X0D68	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
CANDESARTAN	ACTIVE MOIETY	S8Q36MD2XX	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
CARBOXYMETHYLCELLULOSE CALCIUM	INACTIVE INGREDIENT	UTY7PDF93L	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [PHYSICIANS TOTAL CARE, INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ATACAND HCT	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	ANI Pharmaceuticals, Inc.	d91152c4-66ba-466f-b4f9-0da628d42b1d	2025-12-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021093 application number: NDA021093
Candesartan Cilexetil and Hydrochlorothiazide	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	ANI Pharmaceuticals, Inc.	bd8d318d-167a-4b26-935d-265dde3193de	2025-12-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021093 application number: NDA021093

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R85M2X0D68	CANDESARTAN CILEXETIL	145040-37-5	CANDESARTAN CILEXETIL
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
805863	Atacand HCT 16 MG / 12.5 MG Oral Tablet	PSN	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805859	Atacand HCT 32 MG / 12.5 MG Oral Tablet	PSN	8e50e65d-b79b-46b4-a147-796cb19f1407	2
578325	candesartan cilexetil 16 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	8e50e65d-b79b-46b4-a147-796cb19f1407	2
578330	candesartan cilexetil 32 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805863	candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]	SBD	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805859	candesartan cilexetil 32 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]	SBD	8e50e65d-b79b-46b4-a147-796cb19f1407	2
578325	candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet	SCD	8e50e65d-b79b-46b4-a147-796cb19f1407	2
578330	candesartan cilexetil 32 MG / hydrochlorothiazide 12.5 MG Oral Tablet	SCD	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805863	Atacand HCT 16/12.5 Oral Tablet	SY	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805859	Atacand HCT 32/12.5 Oral Tablet	SY	8e50e65d-b79b-46b4-a147-796cb19f1407	2
578325	candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet	SY	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805863	candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]	SY	8e50e65d-b79b-46b4-a147-796cb19f1407	2
578330	candesartan cilexetil 32 MG / HCTZ 12.5 MG Oral Tablet	SY	8e50e65d-b79b-46b4-a147-796cb19f1407	2
805859	candesartan cilexetil 32 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]	SY	8e50e65d-b79b-46b4-a147-796cb19f1407	2

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ATACAND HCT	AstraZeneca Pharmaceuticals LP \| AstraZeneca PLC	2016-07-05	HUMAN PRESCRIPTION DRUG LABEL	26
ATACAND HCT	Physicians Total Care, Inc.	2012-02-02	HUMAN PRESCRIPTION DRUG LABEL	2